Amsterdam, Netherlands

Rieneke Van De Ven

This inventor holds 1 USPTO granted patent. Top assignee: Morgan Stanley Senior Funding, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rieneke Van De Ven. Retrieved from https://idiyas.com/inventor/rieneke-van-de-ven-0jjoytiy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rieneke Van De Ven: Innovator in Cancer Treatment

Introduction

Rieneke Van De Ven is a notable inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of cancer treatment through her innovative research and development.

Latest Patents

Rieneke holds a patent for a groundbreaking method of treating cancer by administering an antibody that binds to 5T4. This patent represents a significant advancement in cancer therapy and showcases her commitment to improving patient outcomes.

Career Highlights

Rieneke is currently employed at Morgan Stanley Senior Funding, Inc., where she continues to work on innovative solutions in the medical field. Her expertise and dedication have positioned her as a valuable asset in her organization.

Collaborations

Rieneke collaborates with talented professionals, including David Satijn and Esther CW Breij, who contribute to her research efforts. Their combined expertise enhances the potential for groundbreaking discoveries in cancer treatment.

Conclusion

Rieneke Van De Ven is a pioneering inventor whose work in cancer treatment is making a difference in the medical community. Her innovative approach and dedication to research exemplify the spirit of invention that drives progress in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…